SEC 13F Intelligence

Saratoga Research & Investment Management / MDT

Saratoga Research & Investment Management’s Medtronic PLC Position

Does Saratoga Research & Investment Management own Medtronic PLC (MDT)? Yes — 1.18M shares worth $102M (+5.78% of its 13F portfolio) as of Q1 2026, up from 1.16M shares the prior filed quarter.

Position Value
$102M
Q1 2026
Shares
1.18M
% of Portfolio
+5.78%
Quarters Held
30
currently held

Position History MDT

Reported value by quarter
Q4 ’18: $35MQ4 ’18Q1 ’19: $35MQ2 ’19: $39MQ3 ’19: $43MQ4 ’19: $44MQ4 ’19Q1 ’20: $48MQ2 ’20: $50MQ3 ’20: $55MQ4 ’20: $64MQ4 ’20Q1 ’21: $64MQ2 ’21: $67MQ3 ’21: $68MQ4 ’21: $56MQ4 ’21Q1 ’22: $84MQ2 ’22: $79MQ3 ’22: $83MQ4 ’22: $77MQ4 ’22Q1 ’23: $92MQ2 ’23: $104MQ3 ’23: $102MQ4 ’23: $104MQ4 ’23Q1 ’24: $119MQ2 ’24: $109MQ3 ’24: $122MQ4 ’24: $90MQ4 ’24Q1 ’25: $106MQ2 ’25: $103MQ3 ’25: $112MQ4 ’25: $111MQ4 ’25Q1 ’26: $102Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.18M$102M+5.78%
Q4 20251.16M$111M+5.82%
Q3 20251.17M$112M+5.80%
Q2 20251.18M$103M+5.51%
Q1 20251.18M$106M+5.60%
Q4 20241.13M$90M+4.55%
Q3 20241.36M$122M+5.35%
Q2 20241.39M$109M+4.98%
Q1 20241.37M$119M+5.42%
Q4 20231.26M$104M+4.79%
Q3 20231.30M$102M+4.97%
Q2 20231.18M$104M+4.78%
Q1 20231.14M$92M+4.35%
Q4 2022990.7K$77M+3.81%
Q3 20221.02M$83M+4.37%
Q2 2022875.3K$79M+3.89%
Q1 2022760.8K$84M+3.67%
Q4 2021545.5K$56M+2.40%
Q3 2021539.9K$68M+3.12%
Q2 2021541.5K$67M+3.17%
Q1 2021543.1K$64M+3.24%
Q4 2020542.8K$64M+3.41%
Q3 2020532.7K$55M+3.32%
Q2 2020546.6K$50M+3.16%
Q1 2020532.7K$48M+3.33%
Q4 2019388.9K$44M+2.65%
Q3 2019391.5K$43M+2.75%
Q2 2019401.3K$39M+2.46%
Q1 2019388.5K$35M+2.42%
Q4 2018386.5K$35M+2.79%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Saratoga Research & Investment Management’s full portfolio or all institutional holders of MDT.